Skip Navigation Bar
 

Unified Medical Language System® (UMLS®)

2012AB MedDRA Czech Source Information

Counts

 (skip to: notes  samples)

Attribute Name Description Count (MRSAT.RRF)
SMQ_TERM_ADDVERSION Standardised MedDRA Query (SMQ) Addition Version. Version of MedDRA in which term was added to the SMQ. 118064
SMQ_TERM_CAT Standardised MedDRA Query (SMQ) Term Category. A single alphabetical letter indicating the category of the term for application of the SMQ algorithm. If the SMQ does not use algorithms, then all Term_category values are assigned "A." For a child SMQ, this field is assigned "S." 118064
SMQ_TERM_LMVERSION Standardised MedDRA Query (SMQ) Last Modified Version. Version of MedDRA in which term was last modified in the SMQ. 118064
SMQ_TERM_SCOPE Standardised MedDRA Query (SMQ) Term Scope. Defines the MedDRA term as a member of the broad scope (1), narrow scope (2) of the SMQ search, or a child SMQ (0) (zero). 118064
SMQ_TERM_STATUS Standardised MedDRA Query (SMQ) Term Status. Identifies a term as active ("A") or inactive ("I") within this SMQ. 118064
SMQ_TERM_WEIGHT Standardised MedDRA Query (SMQ) Term Weight. Used for some SMQ algorithms; "0" is used as default. 118064
SMQ_TERM_LEVEL Standardised MedDRA Query (SMQ) Term Level. The MedDRA hierarchy level of a term (4=PT, 5=LLT) or 0 (zero) for a child SMQ. 39019
MPS MedDRA primary SOC (PTs may have multiple treepositions, but each has a primary soc) 19550
SMQ_ALGO Standardised MedDRA Query (SMQ) Algorithm. Boolean expression of algorithm for the SMQ. "N" if the SMQ does not utilize an algorithm. 203
SMQ_LEVEL Standardised MedDRA Query (SMQ) Level. Value between 1 and 5 identifying the level of the SMQ within the hierarchy of SMQs; 1 is the most general, 5 is the most narrow. 203
SMQ_STATUS Standardised MedDRA Query (SMQ) Status. "A" = active; "I" = inactive. 203
SMQ_SOURCE Standardised MedDRA Query (SMQ) Source. Source for the development of the SMQ, e.g. medical references. 163
SOS Scope Statement 106
MISO MedDRA Serial Code International SOC Sort Order Digit (01-26) 26

Notes

  • Attributes included every discrete piece of information about a concept, an atom, or a relationship that is not part of the basic Metathesaurus concept structure or distributed in one of the relationship files.
  • Attribute Names (ATN) are based on source documentation or NLMs understanding of the source.
  • Sample attribute values (ATV) are provided for each ATN in the source.
  • Sample data highlight examples of ATNs and Attribute Values (ATV) in MRSAT.RRF.
  • See Metathesaurus Documentation for a complete list of attribute names.
  • See Section 2.5 of the UMLS Reference Manual for more information on attributes in the UMLS Metathesaurus.

Sample Data

SMQ_TERM_ADDVERSION

  (return to top)
CUI METAUI STYPE ATN ATV STR
C1869020 R102310338 RUI SMQ_TERM_ADDVERSION 8.0 Jatern infekce (SMQ)
C0476228 R102280819 RUI SMQ_TERM_ADDVERSION 8.1 Lokalizovan povrchov otok, hmota, nebo bulka
C0595929 R102268854 RUI SMQ_TERM_ADDVERSION 8.1 Cholesterol v sru zven
C0543693 R102284566 RUI SMQ_TERM_ADDVERSION 8.1 Novorozeneck neutropenie
C1869035 R102313679 RUI SMQ_TERM_ADDVERSION 8.1 Nedostatečn působivost / efekt (SMQ)
C1869037 R102313803 RUI SMQ_TERM_ADDVERSION 8.1 Perifern neuropatie (SMQ)
C1869039 R102314461 RUI SMQ_TERM_ADDVERSION 9.0 Deprese a sebevražda / sebeporaněn (SMQ)
C1869039 R102314610 RUI SMQ_TERM_ADDVERSION 10.1 Deprese a sebevražda / sebeporaněn (SMQ)
C0155967 R102301014 RUI SMQ_TERM_ADDVERSION 9.0 Akutn žaludečn vřed s krvcenm
C1869042 R102316434 RUI SMQ_TERM_ADDVERSION 9.0 Laboratorn pojmy krvcen (SMQ)
C0595877 R102276239 RUI SMQ_TERM_ADDVERSION 9.0 Glykemie zven
C1869043 R102316854 RUI SMQ_TERM_ADDVERSION 9.0 Hyperglykmie / nov nstup diabetes mellitus (SMQ)
C1869047 R102318189 RUI SMQ_TERM_ADDVERSION 9.0 Systmov lupus erythematosus (SMQ)
C1869050 R102319445 RUI SMQ_TERM_ADDVERSION 9.1 Anticholinergn syndrom (SMQ)
C0920014 R102298491 RUI SMQ_TERM_ADDVERSION 9.1 Hemiblok NOS
C1869062 R102320895 RUI SMQ_TERM_ADDVERSION 9.1 Retroperitoneln fibrza (SMQ)
C0268160 R102273983 RUI SMQ_TERM_ADDVERSION 10.0 Esenciln fruktosurie
C1869073 R102325662 RUI SMQ_TERM_ADDVERSION 10.0 Kongenitln, famililn a genetick poruchy (SMQ)
C0853240 R102283344 RUI SMQ_TERM_ADDVERSION 10.0 Moebiův syndrom

SMQ_TERM_CAT

  (return to top)
CUI METAUI STYPE ATN ATV STR
C1869091 R102309027 RUI SMQ_TERM_CAT A Srdečn selhn (SMQ)
C1869091 R102309082 RUI SMQ_TERM_CAT A Srdečn selhn (SMQ)
C0857323 R102264971 RUI SMQ_TERM_CAT B Angioedm laryngu
C1869026 R102312209 RUI SMQ_TERM_CAT A Agranulocytza (SMQ)
C1869027 R102312633 RUI SMQ_TERM_CAT A Angioedm (SMQ)
C1869027 R102312678 RUI SMQ_TERM_CAT A Angioedm (SMQ)
C1736164 R102307118 RUI SMQ_TERM_CAT A Lokalizovan brněn
C1869039 R102314431 RUI SMQ_TERM_CAT A Deprese a sebevražda / sebeporaněn (SMQ)
C1869039 R102314446 RUI SMQ_TERM_CAT A Deprese a sebevražda / sebeporaněn (SMQ)
C0015402 R102285065 RUI SMQ_TERM_CAT A Očn krvcen
C1869102 R102316035 RUI SMQ_TERM_CAT A Pojmy krvcen (kromě laboratornch pojmů) (SMQ)
C0235467 R102264913 RUI SMQ_TERM_CAT A Zhoren anginy pectoris
C1142436 R102303473 RUI SMQ_TERM_CAT D Syndrom soumraku
C0521471 R102290513 RUI SMQ_TERM_CAT A LE exantm
C1869050 R102319326 RUI SMQ_TERM_CAT D Anticholinergn syndrom (SMQ)
C0003811 R102265379 RUI SMQ_TERM_CAT A Arytmie
C0265088 R102289363 RUI SMQ_TERM_CAT A Krvcen do pontu
C1869062 R102320848 RUI SMQ_TERM_CAT A Retroperitoneln fibrza (SMQ)
C1869069 R102321841 RUI SMQ_TERM_CAT A Stavy hypoglykemickho a neurogenickho oku (SMQ)

SMQ_TERM_LMVERSION

  (return to top)
CUI METAUI STYPE ATN ATV STR
C1869091 R102309071 RUI SMQ_TERM_LMVERSION 10.0 Srdečn selhn (SMQ)
C0160392 R102295923 RUI SMQ_TERM_LMVERSION 11.0 Blže neurčen poraněn jater, bez zmnky otevřenho nitrobřinho poraněn
C1869038 R102311041 RUI SMQ_TERM_LMVERSION 8.1 Anafylaktick reakce (SMQ)
C1869038 R102311502 RUI SMQ_TERM_LMVERSION 8.1 Anafylaktick reakce (SMQ)
C1869038 R102311632 RUI SMQ_TERM_LMVERSION 9.1 Anafylaktick reakce (SMQ)
C1869026 R102312184 RUI SMQ_TERM_LMVERSION 8.1 Agranulocytza (SMQ)
C1869027 R102312243 RUI SMQ_TERM_LMVERSION 8.1 Angioedm (SMQ)
C0020476 R102277959 RUI SMQ_TERM_LMVERSION 8.1 Hyperlipoproteinemie
C1869044 R102317165 RUI SMQ_TERM_LMVERSION 9.0 Intersticiln choroba plic (SMQ)
C0858888 R102266992 RUI SMQ_TERM_LMVERSION 9.0 Mimovoln pohyby těla
C0030567 R102287754 RUI SMQ_TERM_LMVERSION 9.0 Parkinsonova nemoc NOS
C1869047 R102318252 RUI SMQ_TERM_LMVERSION 9.0 Systmov lupus erythematosus (SMQ)
C1869047 R102318417 RUI SMQ_TERM_LMVERSION 9.0 Systmov lupus erythematosus (SMQ)
C1869047 R102318511 RUI SMQ_TERM_LMVERSION 9.0 Systmov lupus erythematosus (SMQ)
C1869050 R102319143 RUI SMQ_TERM_LMVERSION 9.1 Anticholinergn syndrom (SMQ)
C0160219 R102301679 RUI SMQ_TERM_LMVERSION 9.1 Subarachnoidln krvcen porazov bez zmnky otevřenho intrakranilnho poraněn
C1869069 R102321824 RUI SMQ_TERM_LMVERSION 9.1 Stavy hypoglykemickho a neurogenickho oku (SMQ)
C0948008 R102304723 RUI SMQ_TERM_LMVERSION 10.0 Ischemick mozkov přihoda
C1963970 R102339192 RUI SMQ_TERM_LMVERSION 10.1 Zneužvn drog (SMQ)

SMQ_TERM_SCOPE

  (return to top)
CUI METAUI STYPE ATN ATV STR
C0856118 R102297212 RUI SMQ_TERM_SCOPE 1 Zhoren svalov slabosti
C0232815 R102280971 RUI SMQ_TERM_SCOPE 1 Nzk renln clearance
C0151570 R102270858 RUI SMQ_TERM_SCOPE 2 Nepřm Coombsův test pozitivn
C1869038 R102311172 RUI SMQ_TERM_SCOPE 1 Anafylaktick reakce (SMQ)
C1869027 R102312456 RUI SMQ_TERM_SCOPE 2 Angioedm (SMQ)
C0859194 R102269065 RUI SMQ_TERM_SCOPE 2 Chronick obstrukčn astma (s obstrukčnm plicnm onemocněnm), bez zmnky o status asthmaticus
C0020557 R102299426 RUI SMQ_TERM_SCOPE 2 Triglyceridy vysok
C0580547 R102265977 RUI SMQ_TERM_SCOPE 1 Abnormln počet bazofilů NOS
C1869037 R102314051 RUI SMQ_TERM_SCOPE 1 Perifern neuropatie (SMQ)
C0859813 R102270048 RUI SMQ_TERM_SCOPE 1 Kombinovan zvislost na drogch kromě drog morfinovho typu
C0024517 R102281313 RUI SMQ_TERM_SCOPE 2 Velk depresivn porucha, jedin epizoda
C1869043 R102316813 RUI SMQ_TERM_SCOPE 2 Hyperglykmie / nov nstup diabetes mellitus (SMQ)
C1869043 R102317067 RUI SMQ_TERM_SCOPE 2 Hyperglykmie / nov nstup diabetes mellitus (SMQ)
C1869046 R102317553 RUI SMQ_TERM_SCOPE 1 Neuroleptick malign syndrom (SMQ)
C0859084 R102284443 RUI SMQ_TERM_SCOPE 1 Nefritida a nefropatie, neurč jako aktun nebo chron, s nlezem membranoprolifer glomerulonefr
C0235118 R102278790 RUI SMQ_TERM_SCOPE 1 Pokles iniciativy
C1869070 R102322357 RUI SMQ_TERM_SCOPE 1 Demence (SMQ)
C1168248 R102303817 RUI SMQ_TERM_SCOPE 1 Nevhodn řeč
C1869075 R102328561 RUI SMQ_TERM_SCOPE 2 Křeče (SMQ)

SMQ_TERM_STATUS

  (return to top)
CUI METAUI STYPE ATN ATV STR
C1869007 R102308725 RUI SMQ_TERM_STATUS A Rabdomyolza/myopatie (SMQ)
C0854050 R102276208 RUI SMQ_TERM_STATUS A Glomerulrn filtrace abnormln NOS
C1869023 R102310476 RUI SMQ_TERM_STATUS A Hemolytick poruchy (SMQ)
C1869023 R102310596 RUI SMQ_TERM_STATUS A Hemolytick poruchy (SMQ)
C1869024 R102310690 RUI SMQ_TERM_STATUS A Těžk kožn nepřzniv reakce (SMQ)
C1869038 R102311265 RUI SMQ_TERM_STATUS A Anafylaktick reakce (SMQ)
C1869025 R102311670 RUI SMQ_TERM_STATUS A Akutn pankreatititida (SMQ)
C0034189 R102290323 RUI SMQ_TERM_STATUS A Pyemie
C1869026 R102312141 RUI SMQ_TERM_STATUS A Agranulocytza (SMQ)
C1869026 R102312193 RUI SMQ_TERM_STATUS A Agranulocytza (SMQ)
C1869026 R102312224 RUI SMQ_TERM_STATUS A Agranulocytza (SMQ)
C0600260 R102272235 RUI SMQ_TERM_STATUS A Obstrukčn onemocněn plic
C0151602 R102293786 RUI SMQ_TERM_STATUS A Otok obličeje
C0948709 R102299125 RUI SMQ_TERM_STATUS A Edm nosn skořepy
C1869027 R102312694 RUI SMQ_TERM_STATUS A Angioedm (SMQ)
C1869027 R102312704 RUI SMQ_TERM_STATUS A Angioedm (SMQ)
C0740305 R102266357 RUI SMQ_TERM_STATUS A Biopsie kostn dřeně abnormln
C0269684 R102264881 RUI SMQ_TERM_STATUS I Anmie matky komplikujc těhotenstv, porod nebo estineděl bez uveden vztahu k pči nebo lčbě
C1869035 R102313643 RUI SMQ_TERM_STATUS A Nedostatečn působivost / efekt (SMQ)

SMQ_TERM_WEIGHT

  (return to top)
CUI METAUI STYPE ATN ATV STR
C1869038 R102311568 RUI SMQ_TERM_WEIGHT 0 Anafylaktick reakce (SMQ)
C1536101 R102306050 RUI SMQ_TERM_WEIGHT 0 Anafylaktick reakce na vakcinu
C1869026 R102312174 RUI SMQ_TERM_WEIGHT 0 Agranulocytza (SMQ)
C1869028 R102312881 RUI SMQ_TERM_WEIGHT 0 Astma/bronchospazmus (SMQ)
C0678189 R102290294 RUI SMQ_TERM_WEIGHT 0 Izolovan hypercholesterolemie
C1869029 R102313094 RUI SMQ_TERM_WEIGHT 0 Dyslipidemie (SMQ)
C1869037 R102314086 RUI SMQ_TERM_WEIGHT 0 Perifern neuropatie (SMQ)
C0859569 R102272593 RUI SMQ_TERM_WEIGHT 0 Zvislost na drogch u matky, komplikujc těhotenstv, porod nebo estineděl, blže neurčen
C0157393 R102294364 RUI SMQ_TERM_WEIGHT 0 Poporodn krvcen v třet době, s porodem
C1869046 R102317573 RUI SMQ_TERM_WEIGHT 0 Neuroleptick malign syndrom (SMQ)
C0497247 R102291459 RUI SMQ_TERM_WEIGHT 0 Vzestup TK
C1869050 R102318989 RUI SMQ_TERM_WEIGHT 0 Anticholinergn syndrom (SMQ)
C1869050 R102319176 RUI SMQ_TERM_WEIGHT 0 Anticholinergn syndrom (SMQ)
C0035078 R102290947 RUI SMQ_TERM_WEIGHT 0 Blže neurčen renln selhn
C1869067 R102321521 RUI SMQ_TERM_WEIGHT 0 Stavy toxicko-septickho oku (SMQ)
C0859570 R102283107 RUI SMQ_TERM_WEIGHT 0 Duevn poruchy matky komplikujc těhotenstv, porod nebo estineděl, blže neurčen
C1869075 R102328496 RUI SMQ_TERM_WEIGHT 0 Křeče (SMQ)
C0311220 R102306993 RUI SMQ_TERM_WEIGHT 0 Lymphocytoma cutis
C0948800 R102299328 RUI SMQ_TERM_WEIGHT 0 Radioterapie pteře NOS

SMQ_TERM_LEVEL

  (return to top)
CUI METAUI LUI SUI STYPE CODE ATN ATV STR
C0157461 A15815196 L8021332 S10072381 CODE 10001045 SMQ_TERM_LEVEL 5 Akutn renln selhn po porodu
C0574002 A15818613 L8044865 S10081807 CODE 10030134 SMQ_TERM_LEVEL 5 Edematzn noha od kotnku nže
C0877147 A15766739 L8046247 S10092733 CODE 10049125 SMQ_TERM_LEVEL 5 Kardiorespiračn selhn
C0086565 A15813352 L8066098 S10070678 CODE 10019670 SMQ_TERM_LEVEL 4 Abnormln jatern funkce
C0558148 A15755088 L8050919 S10130296 CODE 10040818 SMQ_TERM_LEVEL 5 Žlut zbarven kůže
C0085666 A15776839 L8040739 S10107668 CODE 10041520 SMQ_TERM_LEVEL 5 Pavoučkov nvy
C0162565 A15761009 L8066287 S10072132 CODE 10000818 SMQ_TERM_LEVEL 5 Akutn intermitentn porfyrie
C0022610 A15775402 L8023774 S10092005 CODE 10029814 SMQ_TERM_LEVEL 5 Jdrov ikterus
C0281863 A15750579 L8048783 S10113247 CODE 10002724 SMQ_TERM_LEVEL 5 Protiltky anti-HCV pozitivn
C0262505 A15828263 L8055075 S10102931 CODE 10019737 SMQ_TERM_LEVEL 5 Nosič hepatitidy B
C0160832 A15815670 L8026498 S10113930 CODE 10005211 SMQ_TERM_LEVEL 5 Puchř trupu, bez zmnky o infekci
C0239488 A15795298 L8060147 S10083008 CODE 10015212 SMQ_TERM_LEVEL 5 Erytm obličeje
C0155880 A15774570 L8052476 S10082380 CODE 10022847 SMQ_TERM_LEVEL 5 Endogenn astma
C0234913 A15748943 L8075163 S10082909 CODE 10037855 SMQ_TERM_LEVEL 4 Erytematzn vyržka
C0002064 A15815266 L8021396 S10072867 CODE 10001688 SMQ_TERM_LEVEL 5 Alkalza respiračn
C0948021 A15770734 L8026280 S10112108 CODE 10051313 SMQ_TERM_LEVEL 4 Počet B lymfocytů snžen
C0860752 A15785556 L8069250 S10095565 CODE 10023659 SMQ_TERM_LEVEL 5 Laktt vysok
C0085633 A15775188 L8056339 S10113081 CODE 10027952 SMQ_TERM_LEVEL 5 Proměnliv nlada
C0156042 A15804187 L8043747 S10072472 CODE 10000775 SMQ_TERM_LEVEL 5 Akutn vřed v gastrojejunln anastomze s krvcenm

MPS

  (return to top)
CUI METAUI LUI SUI STYPE CODE ATN ATV STR
C0232495 A15748022 L8059339 S10076835 SDUI 10000084 MPS 10017947 Bolest doln poloviny břicha
C0343752 A15801855 L8043672 S10071906 SDUI 10000807 MPS 10021881 Akutn HIV infekce
C1533150 A15758683 L8036576 S10073832 SDUI 10002150 MPS 10017947 Anln dilatace
C0243065 A15758715 L8066536 S10074031 SDUI 10002961 MPS 10010331 Aplazie
C0002874 A15748098 L8074077 S10074017 SDUI 10002967 MPS 10005329 Aplastick anmie
C0855917 A15758799 L8046301 S10093196 SDUI 10005384 MPS 10022891 Kofein v krvi zven
C0549405 A15780667 L8053861 S10093324 SDUI 10005746 MPS 10047065 Kolsn krevnho tlaku
C0853130 A15791420 L8050071 S10123334 SDUI 10005829 MPS 10022891 Tyreostimulačn hormon v krvi
C0016034 A15802065 L8059949 S10081570 SDUI 10006237 MPS 10038604 Dysplazie prsu
C0579079 A15780690 L8056019 S10110722 SDUI 10006346 MPS 10036585 Porod koncem pnevnm
C0007398 A15769713 L8076464 S10092861 SDUI 10007776 MPS 10037175 Katatonie
C0009069 A15780758 L8026786 S10116348 SDUI 10009668 MPS 10022891 Retrakce koagula
C0151490 A15748325 L8080486 S10125110 SDUI 10010411 MPS 10010331 Vrozen anomlie centrlnho nervovho systmu
C0311245 A15813141 L8050318 S10125236 SDUI 10010428 MPS 10010331 Vrozen cystick nemoc ledvin
C0852650 A15758935 L8031512 S10093823 SDUI 10010835 MPS 10041244 Kontraindikace pro očkovn
C0010691 A15769813 L8074733 S10079442 SDUI 10011778 MPS 10010331 Cystinurie
C0362037 A15813191 L8063526 S10109708 SDUI 10012390 MPS 10022117 Pooperačn deprese
C0013390 A15813221 L8059938 S10081522 SDUI 10013935 MPS 10038604 Dysmenorea
C0278590 A15769885 L8049015 S10115170 SDUI 10015564 MPS 10029104 Recidivujc Ewingův sarkom

SMQ_ALGO

  (return to top)
CUI METAUI LUI SUI STYPE CODE ATN ATV STR
C1869007 A15758371 L8048981 S10114847 SDUI 20000002 SMQ_ALGO N Rabdomyolza/myopatie (SMQ)
C1869091 A15780192 L8079799 S10119295 SDUI 20000004 SMQ_ALGO N Srdečn selhn (SMQ)
C1869014 A15790981 L8075611 S10086221 SDUI 20000010 SMQ_ALGO N Hepatitida, neinfekčn (SMQ)
C1869038 A15823307 L8066417 S10073110 SDUI 20000021 SMQ_ALGO A or (B and C) or (D and (B or C)) Anafylaktick reakce (SMQ)
C1869026 A15790983 L8066241 S10071745 SDUI 20000023 SMQ_ALGO N Agranulocytza (SMQ)
C1869029 A15790984 L8029972 S10081518 SDUI 20000026 SMQ_ALGO N Dyslipidemie (SMQ)
C1869035 A15790986 L8054845 S10101271 SDUI 20000032 SMQ_ALGO N Nedostatečn působivost / efekt (SMQ)
C1869036 A15823309 L8024215 S10095553 SDUI 20000033 SMQ_ALGO N Laktick acidza (SMQ)
C1869042 A15780195 L8024206 S10095446 SDUI 20000040 SMQ_ALGO N Laboratorn pojmy krvcen (SMQ)
C1869043 A15769198 L8030727 S10087396 SDUI 20000041 SMQ_ALGO N Hyperglykmie / nov nstup diabetes mellitus (SMQ)
C1869044 A15790987 L8060975 S10089641 SDUI 20000042 SMQ_ALGO N Intersticiln choroba plic (SMQ)
C1869048 A15758374 L8071158 S10111339 SDUI 20000046 SMQ_ALGO N Poruchy chuti a čichu (SMQ)
C1869049 A15758375 L8053239 S10088624 SDUI 20000047 SMQ_ALGO N Infarkt myokardu (SMQ)
C1869051 A15780197 L8072120 S10119207 SDUI 20000049 SMQ_ALGO N Srdečn arytmie (SMQ)
C1869098 A15780198 L8040940 S10109391 SDUI 20000050 SMQ_ALGO N Pojmy srdečn arytmie (včetně bradyarytmi a tachyarytmi) (SMQ)
C1869053 A15823310 L8068980 S10093624 SDUI 20000052 SMQ_ALGO N Kongenitln a novorozeneck arytmie (SMQ)
C1869099 A15801581 L8051791 S10077219 SDUI 20000053 SMQ_ALGO N Bradyarytmie (včetně poruch veden a poruch funkce sinusovho uzlu) (SMQ)
C1869054 A15758376 L8041181 S10111363 SDUI 20000055 SMQ_ALGO N Poruchy funkce sinusovho uzlu (SMQ)
C1869055 A15758377 L8048599 S10111631 SDUI 20000056 SMQ_ALGO N Poruchy veden (SMQ)

SMQ_LEVEL

  (return to top)
CUI METAUI LUI SUI STYPE CODE ATN ATV STR
C1869007 A15758371 L8048981 S10114847 SDUI 20000002 SMQ_LEVEL 1 Rabdomyolza/myopatie (SMQ)
C1869008 A15801570 L8066319 S10072410 SDUI 20000003 SMQ_LEVEL 1 Akutn selhn ledvin (SMQ)
C1869014 A15790981 L8075611 S10086221 SDUI 20000010 SMQ_LEVEL 4 Hepatitida, neinfekčn (SMQ)
C1869038 A15823307 L8066417 S10073110 SDUI 20000021 SMQ_LEVEL 1 Anafylaktick reakce (SMQ)
C1869025 A15790982 L8073856 S10072290 SDUI 20000022 SMQ_LEVEL 1 Akutn pankreatititida (SMQ)
C1869026 A15790983 L8066241 S10071745 SDUI 20000023 SMQ_LEVEL 1 Agranulocytza (SMQ)
C1869036 A15823309 L8024215 S10095553 SDUI 20000033 SMQ_LEVEL 1 Laktick acidza (SMQ)
C1869041 A15758373 L8061563 S10094664 SDUI 20000038 SMQ_LEVEL 1 Krvcen (SMQ)
C1869042 A15780195 L8024206 S10095446 SDUI 20000040 SMQ_LEVEL 2 Laboratorn pojmy krvcen (SMQ)
C1869043 A15769198 L8030727 S10087396 SDUI 20000041 SMQ_LEVEL 1 Hyperglykmie / nov nstup diabetes mellitus (SMQ)
C1869044 A15790987 L8060975 S10089641 SDUI 20000042 SMQ_LEVEL 1 Intersticiln choroba plic (SMQ)
C1869045 A15801580 L8061032 S10090009 SDUI 20000043 SMQ_LEVEL 1 Ischemick srdečn choroba (SMQ)
C1869046 A15790988 L8070057 S10102179 SDUI 20000044 SMQ_LEVEL 1 Neuroleptick malign syndrom (SMQ)
C1869047 A15780196 L8057313 S10120970 SDUI 20000045 SMQ_LEVEL 1 Systmov lupus erythematosus (SMQ)
C1869049 A15758375 L8053239 S10088624 SDUI 20000047 SMQ_LEVEL 2 Infarkt myokardu (SMQ)
C1869051 A15780197 L8072120 S10119207 SDUI 20000049 SMQ_LEVEL 1 Srdečn arytmie (SMQ)
C1869098 A15780198 L8040940 S10109391 SDUI 20000050 SMQ_LEVEL 2 Pojmy srdečn arytmie (včetně bradyarytmi a tachyarytmi) (SMQ)
C1869099 A15801581 L8051791 S10077219 SDUI 20000053 SMQ_LEVEL 3 Bradyarytmie (včetně poruch veden a poruch funkce sinusovho uzlu) (SMQ)
C1869054 A15758376 L8041181 S10111363 SDUI 20000055 SMQ_LEVEL 4 Poruchy funkce sinusovho uzlu (SMQ)

SMQ_STATUS

  (return to top)
CUI METAUI LUI SUI STYPE CODE ATN ATV STR
C1869009 A15769196 L8061050 S10090153 SDUI 20000005 SMQ_STATUS A Jatern poruchy (SMQ)
C1869012 A15790980 L8073065 S10126437 SDUI 20000008 SMQ_STATUS A Vyetřen, přznaky a symptomy tkajc se jater (SMQ)
C1869014 A15790981 L8075611 S10086221 SDUI 20000010 SMQ_STATUS A Hepatitida, neinfekčn (SMQ)
C1869015 A15812554 L8032513 S10101740 SDUI 20000011 SMQ_STATUS A Neoplazmy jater, malign a nespecifikovan (SMQ)
C1869020 A15801574 L8076090 S10090131 SDUI 20000016 SMQ_STATUS A Jatern infekce (SMQ)
C1869023 A15801576 L8052905 S10086037 SDUI 20000019 SMQ_STATUS A Hemolytick poruchy (SMQ)
C1869024 A15769197 L8072684 S10123500 SDUI 20000020 SMQ_STATUS A Těžk kožn nepřzniv reakce (SMQ)
C1869038 A15823307 L8066417 S10073110 SDUI 20000021 SMQ_STATUS A Anafylaktick reakce (SMQ)
C1869025 A15790982 L8073856 S10072290 SDUI 20000022 SMQ_STATUS A Akutn pankreatititida (SMQ)
C1869026 A15790983 L8066241 S10071745 SDUI 20000023 SMQ_STATUS A Agranulocytza (SMQ)
C1869028 A15758372 L8029086 S10074525 SDUI 20000025 SMQ_STATUS A Astma/bronchospazmus (SMQ)
C1869029 A15790984 L8029972 S10081518 SDUI 20000026 SMQ_STATUS A Dyslipidemie (SMQ)
C1869035 A15790986 L8054845 S10101271 SDUI 20000032 SMQ_STATUS A Nedostatečn působivost / efekt (SMQ)
C1869036 A15823309 L8024215 S10095553 SDUI 20000033 SMQ_STATUS A Laktick acidza (SMQ)
C1869040 A15834185 L8026900 S10117260 SDUI 20000037 SMQ_STATUS A Sebevražda / sebeporaněn (SMQ)
C1869049 A15758375 L8053239 S10088624 SDUI 20000047 SMQ_STATUS A Infarkt myokardu (SMQ)
C1869051 A15780197 L8072120 S10119207 SDUI 20000049 SMQ_STATUS A Srdečn arytmie (SMQ)
C1869053 A15823310 L8068980 S10093624 SDUI 20000052 SMQ_STATUS A Kongenitln a novorozeneck arytmie (SMQ)
C1869099 A15801581 L8051791 S10077219 SDUI 20000053 SMQ_STATUS A Bradyarytmie (včetně poruch veden a poruch funkce sinusovho uzlu) (SMQ)

SMQ_SOURCE

  (return to top)
CUI METAUI LUI SUI STYPE CODE ATN ATV STR
C1869006 A15790979 L8035077 S10121922 SDUI 20000001 SMQ_SOURCE Zipes DP. Specific arrhythmias: diagnosis and treatment. Heart Disease: A Textbook of Cardiovascular Medicine (5th Ed). Braunwald E (Ed). WB Saunders: Philadelphia, 1997, pg. 640-704. Marriott HJL and Conover MB. Polymorphic ventricular tachycardia. Advanced Concepts in Arrhythmias (3rd Ed). Mosby: New York, 1998, pg. 293-310. Definitions and basic requirements for the use of terms for reporting adverse drug reactions (XI): cardiovascular system disorders. Pharmacoepidemiology and Drug Safety 1998; 7:351-357. Torsade de pointes. Reporting Adverse Drug Reactions: Definitions of Terms and Criteria for Their Use. Bankowski Z, Bruppacher R, Crusius I et al (Eds). Council for International Organizations of Medical Sciences: Geneva, 1999, pg. 81-82 Josephson ME and Zimetbaum P. The tachyarrhythmias. Harrison's Principles of Internal Medicine (15th Ed). Braunwald E, Fauci AS, Kasper DL et al (Eds). McGraw-Hill: New York, 2001, pg. 1292-1309. Bauman JL and Schoen MD. Arrhythmias. Pharmacotherapy: A Pathophysiologic Approach (5th Ed). DiPiro JT, Talbert RL, Yee GC et al (Eds). McGraw-Hill: New York, 2002, pg. 273-303. Torsade de pointes/prodloužen QT (SMQ)
C1869008 A15801570 L8066319 S10072410 SDUI 20000003 SMQ_SOURCE The Merck Manual, 17th Edition Cecil Textbook of Medicine, 19th Edition Harrison's Principles of Internal Medicine, 13th Edition Akutn selhn ledvin (SMQ)
C1869024 A15769197 L8072684 S10123500 SDUI 20000020 SMQ_SOURCE Roujeau JC and Stern RS. Severe adverse cutaneous reactions to drugs. New England Journal of Medicine 1994; 331: 1272-1285. Reporting Adverse Drug Reactions. Definitions of terms and criteria for their use. CIOMS publication, Geneva 1999. Těžk kožn nepřzniv reakce (SMQ)
C1869038 A15823307 L8066417 S10073110 SDUI 20000021 SMQ_SOURCE 1 The Merck Manual. 15th edition. Merck, Sharp & Dohme Research Laboratories. (1987): 306-7 Anafylaktick reakce (SMQ)
C1869025 A15790982 L8073856 S10072290 SDUI 20000022 SMQ_SOURCE 1. Anonymous. Pancreatitis. Reporting Adverse Drug Reactions: Definitions of Terms and Criteria for Their Use. Bankowski Z, Bruppacher R, Crusius I et al (Eds). Council for International Organizations of Medical Sciences: Geneva, 1999, pp 53-54 2. Berardi RR and Montgomery PA. Pancreatitis. Pharmacotherapy: A Pathophysiologic Approach (5th Ed). DiPiro JT, Talbert RL, Yee GC et al (Eds). McGraw-Hill: New York, NY. 1999. pp 701-715 3. Greenberger NJ, Toskes PP, and Isselbacher KJ. Acute and chronic pancreatitis. Harrison's Principles of Internal Medicine (14th Ed). Fauci AS, Braunwald E, Isselbacher KJ et al (Eds). McGraw-Hill: New York, NY. 1998. pp 1741-1752 Akutn pankreatititida (SMQ)
C1869027 A15780194 L8043869 S10073375 SDUI 20000024 SMQ_SOURCE 1. Bankowski Z, Bruppacher R, Crusius I et al. Reporting adverse drug reactions, definition of terms and criteria for their use. Council for International Organizations of Medical Sciences (CIOMS) 1999 pp 12 -13 2. Dorland's Illustrated Medical Dictionary, 28th Edition 1994 p78 3. Braunwald E, Fauci A and Kasper D. Harrison's Principles of Internal Medicine, 15th Edition, 2001 p 341 and pp 1917-1918 4. Beers M and Berkow R. The Merck Manual of diagnosis and therapy, 17th edition, dated 1999 pp 1054-56 Angioedm (SMQ)
C1869028 A15758372 L8029086 S10074525 SDUI 20000025 SMQ_SOURCE 1. CIOMS publication, "Reporting Adverse Drug Reactions: Definitions of Terms and Criteria for their Use", pp 89 - 90, 1999.2. The Merck Manual, Seventeenth Edition, pp 556 - 568, 1999. 3. "Harrison's Principles of Internal Medicine", 14th edition, pp 1419 - 1426, 1998. Astma/bronchospazmus (SMQ)
C1869036 A15823309 L8024215 S10095553 SDUI 20000033 SMQ_SOURCE 1. Braunwald E, Fauci A, Kasper D. Harrison's Principles of Internal Medicine. 15th Edition, 2001 pp 285-9 2. Weatherall D, Ledingham J and Warrell D. Oxford Textbood of Medicine. Third edition, 1996; volume 2 pp 1541-44 Laktick acidza (SMQ)
C1869039 A15801579 L8074823 S10080108 SDUI 20000035 SMQ_SOURCE 1) Definitions and basic requirements for the use of terms for reporting adverse drug reactions (IV). Pharmacoepidemiology and Drug Safety 1993; 2:149-153. 2) Depression. Reporting Adverse Drug Reactions: Definitions of Terms and Criteria for Their Use. Bankowski Z, Bruppacher R, Crusius I et al (Eds). Council for International Organizations of Medical Sciences: Geneva, 1999, pg. 43. 3) Kando JC, Wells BG, and Hayes PE. Depressive disorders. Pharmacotherapy: A Pathophysiologic Approach (5th Ed). DiPiro JT, Talbert RL, Yee GC et al (Eds). McGraw-Hill: New York, 2002, pg. 1243-1264. 4) Major depressive episode. Diagnostic and Statistical Manual of Mental Disorders (4th Ed). American Psychiatric Association: Washington DC, 1994, pg. 320-327. 5) Major depressive disorder. Diagnostic and Statistical Manual of Mental Disorders (4th Ed). American Psychiatric Association: Washington DC, 1994, pg. 370-375. 6) Substance-induced mood disorder. Diagnostic and Statistical Manual of Mental Disorders (4th Ed). American Psychiatric Association: Washington DC, 1994, pg. 370-375. 7) Dysthymic disorder. Diagnostic and Statistical Manual of Mental Disorders (4th Ed). American Psychiatric Association: Washington DC, 1994, pg. 345-350. 8) Minor depressive disorder. Diagnostic and Statistical Manual of Mental Disorders (4th Ed). American Psychiatric Association: Washington DC, 1994, pg. 719-721. Deprese a sebevražda / sebeporaněn (SMQ)
C1869043 A15769198 L8030727 S10087396 SDUI 20000041 SMQ_SOURCE 1. Oki JC and Isley WL. Diabetes mellitus. Pharmacotherapy: A Pathophysiologic Approach (5th Ed). DiPiro JT, Talbert RL, Yee GC et al (Eds). McGraw-Hill: New York, 2002. pg. 1335-1358. 2. Powers AC. Diabetes mellitus. Harrison's Principles of Internal Medicine (15th Ed). Braunwald E, Fauci AS, Kasper DL et al (Eds). McGraw-Hill: New York, 2001. pg. 2109-2137. 3. Vanrenterghem YFC. Which calcerineurin inhibitor is preferred in renal transplantation: tacrolimus or cyclosporine? Curr Opin Nephrol Hypertension 1999; 8(6):669-674. 4. Fraenkel PG, Rutkove SB, Matheson JK et al. Induction of myasthenia gravis, myositis, and insulin-dependent diabetes mellitus by high-dose interleukin-2 in a patient with renal cell cancer. J Immunother 2002; 25(4):373-378. 5. Costa J. Corticotrophins and corticosteroids. Meyler's Side Effects of Drugs (14th Ed). Dukes MNG (Ed). Elsevier:Amsterdam, 2000. pg. 1364-1395. 6. Coates P. Miscellaneous hormones. . Meyler's Side Effects of Drugs (14th Ed). Dukes MNG (Ed). Elsevier:Amsterdam, 2000. pg. 1520-1526. 7. Heck AM, Yanovski LA, and Calis KA. Pituitary gland disorders. Pharmacotherapy: A Pathophysiologic Approach (5th Ed). DiPiro JT, Talbert RL, Yee GC et al (Eds). McGraw-Hill: New York, 2002. pg. 1395-1411. 8. Currier J. Management of metabolic complications of therapy. AIDS 2002; 16(Suppl 4):S171-S176. 9. Fantry LE. Protease inhibitor-associated diabetes mellitus: a potential cause of morbidity and mortality. JAIDS 2003; 32: 243-244. 10. Henderson DC. Atypical antipsychotic-induced diabetes mellitus. CNS Drugs 2002; 16(2):77-89. 11. Citrome LL. The increase in risk of diabetes mellitus from exposure to second-generation antipsychotic agents. Drugs of Today 2004; 40(5):445-464. 12. Melkersson K and Dahl M-L. Adverse metabolic effe Hyperglykmie / nov nstup diabetes mellitus (SMQ)
C1869045 A15801580 L8061032 S10090009 SDUI 20000043 SMQ_SOURCE Harrison's Textbook of Internal Medicine Ischemick srdečn choroba (SMQ)
C1869047 A15780196 L8057313 S10120970 SDUI 20000045 SMQ_SOURCE 1. Guidelines for referral and management of systemic lupus erythematosus in adults. American College of Rheumatology Ad Hoc Committee on Systemic Lupus Erythematosus Guidelines. Arthritis Rheum 1999;42:1785-96. 2. Hellman DB, Stone JH. Arthritis and musculoskeletal disorders. In: Tierney, Jr. LM, McPhee SJ, Papadakis MA, editors. Current medical diagnosis and treatment. 43rd ed. New York: McGraw-Hill Companies, Inc.; 2004. Available via intranet at STAT!Ref Online Medical Database. Teton Data Systems, Jackson, Wyo. (Version 3.3.6, 2004). 3. Hahn BH. Disorders of the immune system, connective tissues, and joints. In: Kasper DL, Fauci AS, Longo DL, Braunwald E, Hauser SL, Jameson JL, editors. Harrison's principles of internal medicine. 16th ed. New York: McGraw-Hill Companies; 2005. Available via intranet at STAT!Ref Online Medical Database. Teton Data Systems, Jackson, Wyo. (Version 3.3.6, 2004). 4. Diffuse connective tissue disease. In: Beers MH, Berkow R, editors. The merck manual of diagnosis and therapy. 11th ed. Whitehouse Station: Merck Research Laboratories; 1999. Available via intranet at STAT!Ref Online Medical Database. Teton Data Systems, Jackson, Wyo. (Version 3.3.6, 2004). 5. Trethewey P. Systemic Lupus Erythematosus. Dimens Crit Care Nurs 2004;23:111-5. 6. CIOMS Publication, "Reporting Adverse Drug Reactions: Definitions of Terms and Criteria for their Use", pp 19 - 20, 1999. 7. The Merck Manual, Seventeenth Edition, pp 426 - 430, 1999 8. "Harrison's Principles of Internal Medicine", 14th edition, pp 1874 - 1880, 1998 9. Stratton MA Drug-induced systemic lupus erethemetosis. Clin Pharm 1985: 4:567-63 10. Yung R, Chang S, Hemati N et al. Mechanisms of drug-induced lupus. IV. Comparison of procainamide and hydralazine with analogs in vitro and Systmov lupus erythematosus (SMQ)
C1869048 A15758374 L8071158 S10111339 SDUI 20000046 SMQ_SOURCE 1. The Merck Manual, 17th ed., 1999, p 687 2. Harrison's Principles of Internal Medicine, 14th ed., 1998, pp 173 - 175 3. Doty, RL et al. Influences of antihypertensive and antihyperlipidemic drugs on the senses of taste and smell: a review. J Hypertens21: 1805 -1813 4. Stedman's Medical Dictionary, 27th ed., 2000. Poruchy chuti a čichu (SMQ)
C1869060 A15780201 L8068517 S10090010 SDUI 20000063 SMQ_SOURCE The Merck Manual (Seventeenth Edition), 1999 Ischemick cerebrovaskulrn stavy (SMQ)
C1869061 A15780202 L8045403 S10086108 SDUI 20000064 SMQ_SOURCE The Merck Manual (Seventeenth Edition), 1999 Hemoragick cerebrovaskulrn stavy (SMQ)
C1869062 A15769200 L8064358 S10116381 SDUI 20000065 SMQ_SOURCE 1. CIOMS, Reporting Adverse Drug Reactions, 1999, p 20-21. 2. Khan, AN. Retroperitoneal fibrosis. 13 September 2002. http://www.emedicine.com/radio/topic605.htm. 3. Diamond, JR. Clinical manifestations and diagnosis of retroperitoneal fibrosis. UpToDate(r), 27 February 2005 http://www.utdol.com/ Retroperitoneln fibrza (SMQ)
C1869063 A15758378 L8043435 S10130051 SDUI 20000066 SMQ_SOURCE 1. Harrison's Principles of Internal Medicine 16th ed, Mc Graw Hill, 2005, pp 1581, 1600-1605 2. Dorland's Illustrated Medical Dictionary, 28th ed, Philadelphia WB Saunders Co. 3. Reporting Adverse Drug Reactions, Definitions and Criteria for Their Use, CIOMS, Geneva, 1999 4. Harrison's Principles of Internal Medicine 16th ed, Mc Graw Hill, 2005, pp 1367-71 ok (SMQ)
C1869066 A15801584 L8034775 S10119481 SDUI 20000069 SMQ_SOURCE 1. Harrison's Principles of Internal Medicine 16th ed, Mc Graw Hill, 2005, pp 1581, 1600-1605 2. Dorland's Illustrated Medical Dictionary, 28th ed, Philadelphia WB Saunders Co. 3. Reporting Adverse Drug Reactions, Definitions and Criteria for Their Use, CIOMS, Geneva, 1999 4. Harrison's Principles of Internal Medicine 16th ed, Mc Graw Hill, 2005, pp 1367-71 Stavy hypovolemickho oku (SMQ)
C1869067 A15790990 L8027203 S10119501 SDUI 20000070 SMQ_SOURCE 1. Harrison's Principles of Internal Medicine 16th ed, Mc Graw Hill, 2005, pp 1581, 1600-1605 2. Dorland's Illustrated Medical Dictionary, 28th ed, Philadelphia WB Saunders Co. 3. Reporting Adverse Drug Reactions, Definitions and Criteria for Their Use, CIOMS, Geneva, 1999 4. Harrison's Principles of Internal Medicine 16th ed, Mc Graw Hill, 2005, pp 1367-71 Stavy toxicko-septickho oku (SMQ)

SOS

  (return to top)
CUI METAUI LUI SUI STYPE CODE ATN ATV STR
C1869006 A15790979 L8035077 S10121922 SDUI 20000001 SOS 1. Zahrnuje pojmy nhl a srdečn smrti, protože jde o čast spojen s with torsade de pointes. Torsade de pointes/prodloužen QT (SMQ)
C1869007 A15758371 L8048981 S10114847 SDUI 20000002 SOS 1. Zhoren / selhn ledvin zahrnuto kvůli častmu spojen s rabdomyolzou Rabdomyolza/myopatie (SMQ)
C1869091 A15780192 L8079799 S10119295 SDUI 20000004 SOS Pracovn skupina CIOMS debatovala podrobně o tom, zda by se mohl aplikovat algoritmus na tento SMQ na zkladě uveden definice srdečnho selhn. Takov algoritmus vak nebyl testovn pracovn skupinou CIOMS, a pracovn skupina proto žd uživatele, aby dodali komentř k praktick relevanci algoritmickho přstupu. Takov algoritmus by měl zahrnovat irok pojmy, a to: jeden pojem pro edm, jedem pro dyspoe plus jeden pro klinick projev / přznak / symptom nebo vyetřen, což by tvořilo celkem 3 pojmy. Srdečn selhn (SMQ)
C1869038 A15823307 L8066417 S10073110 SDUI 20000021 SOS Použv se nsledujc altoritmus: Vechny pojmy zkho vyhledvn, stejně jako: Pokud je přtomen jeden termn kategorie B a jeden termn kategorie C, nebo Pokud je přtomen jeden pojem z (kategorie B nebo kategorie C) plus jeden pojem z kategorie D. Anafylaktick reakce (SMQ)
C1869025 A15790982 L8073856 S10072290 SDUI 20000022 SOS Při aplikaci algoritmu tohoto SMQ se zprva pokld za relevantn přpad pro dal analzu, pokud1) zahrnuje pojem kategorie ANEBO 2) zahrnuje alespoň jeden pojem kategorie B (seznam laboratornch hodnot) a alespoň jeden pojem kategorie C (seznam znmek a symprotmů) Akutn pankreatititida (SMQ)
C1869026 A15790983 L8066241 S10071745 SDUI 20000023 SOS Pokud je to možn, pln krevn obrazy a opakovan počty blch krvinek by se měly hlsit, vyhledvat pro nsledn kontroly a kdovat. Co se tče databzovch dotazů se irokmi pojmy vyhledvn, dodatečně kdovan data hematologickch hodnot napomhaj k snadnějmu vyhledvn relevantnch přpadů. V přpadě, že laboratorn hodnoty nejsou v databzi zakdovny, bude potřeba samostatn kontrola, aby se rozhodlo o relevanci dat v kontextu agranulocytzy. Agranulocytza (SMQ)
C1869035 A15790986 L8054845 S10101271 SDUI 20000032 SOS V současnosti je tento SMQ nejvhodněj pro lky a droby, krevn komponenty / derivty a buněčn, tkňov a genoterapeutick produkty. Je mně vhodn pro vakcinov produkty, kter se zdaj bt lpe vyhovujc pro specializovan vyhledvn popsan v tomto dokumentu. Tento SMQ nemůže uživatel modifikovat pro specifick typy a třdy produktů. Podrobnosti viz vodn přručka SMQ. Nedostatečn působivost / efekt (SMQ)
C1869036 A15823309 L8024215 S10095553 SDUI 20000033 SOS Testovn ve dvou regulačnch databzch potvrdilo, že seznam pojmů je adekvtn; v jedn regulačn databzi identifikoval pojem "acidzy" přpady, ale může to bt fenomn charakteristik databze (kdovn doslovnch pojmů podle pojmů stař terminologie nebo jinch konvenc kdovn). Laktick acidza (SMQ)
C1869039 A15801579 L8074823 S10080108 SDUI 20000035 SOS PT Změrn předvkovn a Otrava byly zahrnuty jak ve vyhledvn Deprese, tak ve vyhledvn Deprese a sebevražda / sebeporaněn, protože zahrnuj LLT navdějc na sebevraždu nebo sebeporaněn. Zahrnut těchto PT (zejmna PT Změrn předvkovn) vak podstatně zvilo počet přpadů identifikovanch vyhledvnm deprese i sebevraždy / sebeporaněn ve fzi I testovn. Testovac společnost kdovala jakkoli přpad, kdy byla pacientovi předepsna dvka, kter překročila maxiln na etiketě uvedenou denn dvku, jako změrn předvkovn, bez ohledu na to, zda bylo nebo nebylo hleno. Proto mnoho z těchto přpadů neznamen opravdov "předvkovn". U databz, kde je to běžnou prax, by nebylo nepřiměřen provdět počtečn vyhledvn s vyloučenm těchto dvou PT. U databz, kde to nen běžnou prax, se tyto dva PT mus rutinně zahrnout do obou vyhledvn. Deprese a sebevražda / sebeporaněn (SMQ)
C1869041 A15758373 L8061563 S10094664 SDUI 20000038 SOS PT Krev v moči byl zahrnut, i když by to mohlo bt interpretovno pouze jako laboratorn test bez vslovnho konstatovn, že krev byla přtomn v moči. Tento termn se vak obvykle použv, aby se popsal nlez krve v moči. Poznmka: Kdovači měli zvolit PT Krev v moči přtomn, pokud bylo změrem kdovat přtomnost krve v moči (zjitěnou makroskopicky i bez testu). Krvcen (SMQ)
C1869043 A15769198 L8030727 S10087396 SDUI 20000041 SOS Ve fzi I testovn (databze společnosti) někter pojmy PT irokho vyhledvn (Krevn cholesterol zven, Krevn triglyceridy zven, Vha snžen a Vha zven) vyvolaly značn "um", ale to může zviset na lcch zvolench pro testovn. Pracovn skupina CIOMS rozhodla, že tyto PT se nemusej zahrnovat kvůli kompletnosti, a pokud se při zkm vyhledvn identifikuje dostatečn počet přpadů ke kontrole, pak přpady s hlenm těchto PT mus bt zkontrolovny, aby se určilo, zda pacienti v těchto přpadech se zdaj bt pod vysokm rizikem nslednho vvoje diagetes mellitus nebo hyperglykmie. Testovn v regulačn databzi podobně vyvolalo "um" u PT Vha zven; pracovn skupina CIOMS vak dola k nzoru, že tento pojem je relevantn pro rozsah SMQ a měl by proto zatm zůstat v dotazovn. Uživatel MedDRA se ždaj, aby se specificky soutředili na tento pojem během testovn fze II a aby poskytli podněty ohledně veobecn užitečnosti tohoto SMQ. Hyperglykmie / nov nstup diabetes mellitus (SMQ)
C1869045 A15801580 L8061032 S10090009 SDUI 20000043 SOS Na zkladě regulačnho testovn a testovn společnosti je SMQ Ischemick srdečn choroba schopen vyhledat relevantn přpady. - Původn verze irokho vyhledvn zahrnovala PT Asparttaminotransferza abnormln a PT Asparttaminotransferza zven. - Tyto pojmy byly vyloučeny na zkladě vsledků testovn (vyhledvaly velk počet irelevantnch přpadů).- Při kontrole star dat (tj. z doby před rokem 2000) může abonent zvžit, zda zahrnout tyto pojmy do vyhledvn. - Pozůstv z hlavnho vyhledvn SMQ Ischemick srdečn choroba a jedinho podřzenho vyhledvn SMQ Infarkt myokardu, oboje při zkm i irokm vyhledvn. (POZNMKA: Vechny tyto pojmy v SMQ Infakrt myokardu jsou tak v rozshlejm SMQ Ischemick srdečn choroba.) Ischemick srdečn choroba (SMQ)
C1869046 A15790988 L8070057 S10102179 SDUI 20000044 SOS Algoritmus: Kategorie A: specifick zprvy o NMS nebo podobnch stavech serotoninovho syndromu nebo malign hypertermie;Kategorie B (PT tkajc se horečky)Kategorie C (PT tkajc se svalov rigidity nebo souvisejc se zraněnm)Kategorie D (ostatn relevantn PT tkajc se NMS)Přpady zvolen pro dal kontroly by zahrnovaly vechny přpady hlen přinejmenm jednoho PT uvděnho u kategorie A nebo jakkoli přpad hlen nějak kombinace alespoň jednoho PT z každ ze tř skupin PT uvděnch jako kategorie B, C a D. Neuroleptick malign syndrom (SMQ)
C1869047 A15780196 L8057313 S10120970 SDUI 20000045 SOS Použit vženho algoritmu u tohoto SMQ: 1. PT zmněn v přpadov zprvě se seskup podle předem stanovench kategori. Vskyt mnohonsobnch PT v rmci kategorie se počt jen jednou. 2. Kategorie, kter se pojem připisuje, se pak nsob empiricky předem definovanm vženm" (napřklad třemi u kategori Porucha krve, Serozitida a Imunologick porucha) a vypočte se součet vech kategori. 3. Pokud je tento součet vy než est, navrhujeme, aby se přpadov zprva kvalifikovala jako zprva s podezřenm na SLE. Napřklad přpadov zprva, kter m PT v kategorich Porucha krve (3), Imunologick porucha (3) a Ledvinov porucha (1) se bude klasifikovat jako přpadov zprva irokho vyhledvn SLE (3 + 3 + 1 = 7). Systmov lupus erythematosus (SMQ)
C1869048 A15758374 L8071158 S10111339 SDUI 20000046 SOS Ve fzi I testovn byly přpady v testovac databzi společnosti popisujc nepřjemn chutě a zpachy lčiv ltky rovněž kdovny s použitm stejnch pojmů (tj. PT Dysgeuzie).Pro rozlien zprv o porue a fyzickch vlastnostech lčiv ltky je třeba provst lkařskou analzu Poruchy chuti a čichu (SMQ)
C1869050 A15834187 L8043902 S10073684 SDUI 20000048 SOS Kategorie A (zk): Přpady kdovan na PT Anticholinergn syndrom.Kategorie B, C a D (irok): Kategorie B (PT tkajc se nervovho systmu)Kategorie C (PT tkajc se psychiatrickch poruch)Kategorie D (Ostatn relevantn PT tkajc se anticholinergnho syndromu)Přpady, kter budou vybrny pro dal analzu, by mohly zahrnovat ty přpady, kter zmiňuj alespoň jeden z PT uvděnch u kategorie A nebo ty přpady, kter zmiňuj nějakou kombinaci alespoň jednoho PT z každ ze tř skupin PT uvděnch jako kategorie B, C a D. Poznmka: Někteř zpravodajov zahrnuli pouze termny SOC Psychiatrick poruchy; jinni zahrnuli pouze pojmy netkajc se CNS. Pokud se považuje za důležit, aby se tyto přpady identifikovaly, měl by se použt nealgoritmick přstup pro irok vyhledvn; tento přstup vak může identifikovat velk počet irelevantnch přpadů. Anticholinergn syndrom (SMQ)
C1869051 A15780197 L8072120 S10119207 SDUI 20000049 SOS Pro testovn fze II se abonenti ždaj, aby testovali SMQ Srdečn arytmie a jeho podřzen vyhledvn s vjimkou podřzenho vyhledvn Torsade de pointes / prodloužen QT, kter bylo pro fzi II už distribuovno a je v současnosti v produkci. Srdečn arytmie (SMQ)
C1869070 A15823313 L8052152 S10080025 SDUI 20000073 SOS Na zkladětestovn se PT Porucha pozornosti, Amnzie, Nespavost, PT Halucinace, PT Podržděnost - a možn PT Stav zmatenosti -nejevily jako užitečn. Po prodiskutovn vsledků testovn s pracovn skupinou CIOMS bylo rozhodnuto, že PT Porucha pozornosti, PT Nespavost a PT Podržděnost budou vyloučeny z SMQ, pojmy amnzie a halucinace zůstanou v SMQ a konkrtně dolo k přidn PT Amnestick porucha Demence (SMQ)
C1869082 A15758381 L8024110 S10094549 SDUI 20000086 SOS Uživatel mohou upřesnit vyhledvn rozlienm mezi "obligtnmi" lzemi (rozhodn nebo pravděpodobn vvoj k malignitě)a fakultativnmi" lzemi (možn vvoj) Krevn prekancerzn poruchy (SMQ)

MISO

  (return to top)
CUI METAUI LUI SUI STYPE CODE ATN ATV STR
C0018799 A15812571 L8027176 S10119287 SDUI 10007541 MISO 11 Srdečn poruchy
C0851353 A15790998 L8041184 S10111412 SDUI 10005329 MISO 03 Poruchy krve a lymfatickho systmu
C0027765 A15780216 L8041192 S10111479 SDUI 10029205 MISO 08 Poruchy nervovho systmu
C0015397 A15801598 L8041195 S10111498 SDUI 10015919 MISO 09 Poruchy oka
C0851354 A15780217 L8071188 S10111621 SDUI 10013993 MISO 10 Poruchy ucha a labyrintu
C0851355 A15801599 L8064336 S10116197 SDUI 10038738 MISO 13 Respiračn, hrudn a mediastinln poruchy
C0017178 A15769216 L8052766 S10084855 SDUI 10017947 MISO 14 Gastrointestinln poruchy
C0042075 A15790999 L8048568 S10111420 SDUI 10038359 MISO 18 Poruchy ledvin a močovch cest
C0178298 A15769217 L8026201 S10111416 SDUI 10040785 MISO 16 Poruchy kůže a podkožn tkně
C0263660 A15801600 L8063776 S10111601 SDUI 10028395 MISO 17 Poruchy svalov a kostern soustavy a pojivov tkně
C0014130 A15801601 L8037621 S10082434 SDUI 10014698 MISO 05 Endokrinn poruchy
C0851358 A15780219 L8063748 S10111429 SDUI 10027433 MISO 06 Poruchy metabolismu a vživy
C0009450 A15780220 L8053262 S10088775 SDUI 10021881 MISO 01 Infekce a infestace
C0947733 A15769219 L8048486 S10110687 SDUI 10022117 MISO 24 Poraněn, otravy a procedurln komplikace
C0027651 A15791000 L8025182 S10103350 SDUI 10029104 MISO 02 Novotvary benign, malign a blže neurčen (zahrnujc cysty a polypy)
C1948041 A15791001 L8044446 S10078213 SDUI 10042613 MISO 25 Chirurgick a lčebn postupy
C0042373 A15812573 L8067245 S10079602 SDUI 10047065 MISO 12 Cvn poruchy
C0851362 A15769222 L8044391 S10077838 SDUI 10018065 MISO 22 Celkov poruchy a reakce v mstě aplikace
C0851363 A15758392 L8027202 S10119497 SDUI 10036585 MISO 19 Stavy spojen s těhotenstvm, estinedělm a perinatlnm obdobm